Wais Marta, Tepperman Elissa, Bernardini Marcus Q, Gien Lilian T, Jimenez Waldo, Murji Ally
Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON.
Department of Obstetrics and Gynecology, McMaster University, Hamilton, ON.
J Obstet Gynaecol Can. 2017 Aug;39(8):652-658. doi: 10.1016/j.jogc.2017.03.090.
Professional societies have recently urged gynaecologists to counsel patients about the risks of encountering uterine sarcoma at fibroid surgery especially when morcellation is used. Our objective was to learn the preoperative and postoperative characteristics of patients with uterine sarcoma to better counsel patients undergoing surgery for presumably benign fibroids.
This is a multicentre, retrospective cohort study. Three academic tertiary cancer centres in Southern Ontario over a 13-year period (2001-2014). Patients diagnosed with leiomyosarcoma or endometrial stromal sarcoma were included after identification using pathology databases. A retrospective chart review was conducted to determine clinical characteristics and survival data.
The study included 302 patients with uterine sarcomas (221 leiomyosarcomas, 81 endometrial stromal sarcomas). Mean age at diagnosis was 55 years, and 59% were postmenopausal. Sarcoma diagnosis was made following endometrial sampling (25%), hysterectomy (69% laparotomy, 2.7% laparoscopic/vaginal), and myomectomy (3.3%). Of all the patients who underwent endometrial sampling, 65% were diagnosed with a uterine sarcoma in this manner. A general gynaecologist performed the primary surgical procedure in 166 of 302 patients (55%). Tumour disruption at the time of primary surgery occurred in 57 of 295 patients (19%): subtotal hysterectomy (21), myomectomy (10), dissection of adherent tumour (17), and morcellation (9). Morcellation, to facilitate a minimally invasive approach, was performed with scalpel (2 at laparotomy, 5 vaginally) and with a laparoscopic electro-mechanical morcellator (2). At a median follow-up of 2.9 years, there was no significant difference in survival for stage I and II patients with tumour disruption (n = 32) compared with those without tumour disruption (n = 143), regardless of sarcoma type (P = 0.6).
The majority of patients with uterine sarcomas were postmenopausal. Many can be diagnosed preoperatively with endometrial sampling. Forty-one percent of patients with uterine sarcomas had a high preoperative index of suspicion, resulting in intervention by an oncologist. Morcellation with laparoscopic electro-mechanical morcellator was rare.
专业协会最近敦促妇科医生就肌瘤手术中尤其是使用粉碎术时遭遇子宫肉瘤的风险向患者提供咨询。我们的目的是了解子宫肉瘤患者的术前和术后特征,以便更好地为疑似良性肌瘤接受手术的患者提供咨询。
这是一项多中心回顾性队列研究。在安大略省南部的三个学术性三级癌症中心进行了为期13年(2001 - 2014年)的研究。通过病理数据库识别出诊断为平滑肌肉瘤或子宫内膜间质肉瘤的患者。进行回顾性病历审查以确定临床特征和生存数据。
该研究纳入了302例子宫肉瘤患者(221例平滑肌肉瘤,81例子宫内膜间质肉瘤)。诊断时的平均年龄为55岁,59%为绝经后患者。肉瘤诊断是在子宫内膜取样后做出的(25%),子宫切除术后(69%为剖腹手术,2.7%为腹腔镜/阴道手术),以及肌瘤切除术后(3.3%)。在所有接受子宫内膜取样的患者中,65%以此方式被诊断为子宫肉瘤。302例患者中有166例(55%)由普通妇科医生进行了初次手术。295例患者中有57例(19%)在初次手术时出现肿瘤破裂:次全子宫切除术(21例)、肌瘤切除术(10例)、粘连肿瘤剥离术(17例)和粉碎术(9例)。为便于采用微创方法进行的粉碎术,使用手术刀进行(剖腹手术2例,经阴道5例)以及使用腹腔镜电动粉碎器进行(2例)。中位随访2.9年时,I期和II期有肿瘤破裂的患者(n = 32)与无肿瘤破裂的患者(n = 143)相比,生存率无显著差异,无论肉瘤类型如何(P = 0.6)。
大多数子宫肉瘤患者为绝经后患者。许多患者可通过子宫内膜取样在术前得到诊断。41%的子宫肉瘤患者术前怀疑指数较高,因此由肿瘤学家进行了干预。使用腹腔镜电动粉碎器进行粉碎术的情况很少见。